Basically Scientific Research
Effect of miR-20b on the motor dysfunction after traumatic brain injury in mice and the underlying mechanism
Zhao Chengcheng, Liu Yufei, Li Yun, He Yi, Zhang Xiejun, Li Weiping
Published 2022-03-15
Cite as Chin J Trauma, 2022, 38(3): 260-267. DOI: 10.3760/cma.j.cn501098-20211022-00544
Abstract
ObjectiveTo investigate effect of miR-20b on the motor dysfunction after traumatic brain injury (TBI) in mice and the underlying mechanism.
MethodsSixty C57BL/6J mice were divided into sham group, TBI group and TBI+miR-20b Agomir (Agomir-20b) group according to the random number table, with 20 mice per group. A model of severe TBI was induced by controlled cortical impact. After injury, the mice in TBI group were subjected to tail-vein injection of 200 μl Agomir-negative control at dosage of 50 μmol/L and the mice in TBI+Agomir-20b group were subjected to tail-vein injection of 200 μl Agomir-20b at dosage of 50 μmol/L. At days 3 and 7 postinjury, the rate of neuronal apoptosis in the pericontusional region was detected by TUNEL assay, expression levels of apoptosis-related proteins in the pericontusional region were detected by Western blot analysis, including cleaved caspase-3, cleaved poly adenosine diphosphate-ribose polymerases (PARP), B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax), motor function was evaluated by beam walking test, and expression levels of cytokine mRNAs in the pericontusional region were detected by real-time quantitative PCR (RT-qPCR), including interleukin (IL)-1β, IL-6, IL-10, inducible nitric oxide synthase (iNOS), arginase (Arg) and macrophage mannose receptor 1 (CD206).
ResultsIn TUNEL assay, the rate of neuronal apoptosis in sham group was significantly lower than that in TBI group and TBI+Agomir-20b group at days 3 and 7 postinjury (all P<0.01), and there was a significantly lower rate of neuronal apoptosis in TBI+Agomir-20b group as compared with TBI group (all P<0.01). In Western blot analysis, significantly increased levels of cleaved caspase-3, cleaved PARP and Bax proteins and lowered level of Bcl-2 protein were observed in TBI group at days 3 and 7 postinjury as compared with sham group (all P<0.01); similar levels of cleaved caspase-3, cleaved PARP and Bax proteins were found in TBI+Agomir-20b group at days 3 and 7 postinjury as compared with sham group (all P>0.05), and level of Bcl-2 protein in TBI+Agomir-20b group also showed no obvious variation at day 7 postinjury as compared with sham group (P>0.05) in regardless of a significant reduction at day 3 postinjury (P<0.01). Significantly increased levels of cleaved caspase-3, cleaved PARP and Bax proteins as well as a significantly reduced level of Bcl-2 protein were found in TBI group at days 3 and 7 postinjury as compared with TBI+Agomir-20b group (all P<0.05 or 0.01). In beam walking test, the latency and foot slip rate in TBI group were significantly higher than those in sham group and TBI+Agomir-20b group at days 3 and 7 postinjury (all P<0.01). In RT-qPCR analysis, levels of IL-1β, IL-6 and iNOS mRNA in TBI group were significantly higher than those in TBI+Agomir-20b group at days 3 and 7 postinjury (all P<0.01), but the two groups were similar in levels of IL-10, Arg and CD206 mRNA (all P>0.05). In comparison with sham group, levels of IL-1β, IL-6, iNOS and IL-10 mRNA in TBI+Agomir-20b group had no obvious change at days 3 and 7 postinjury (all P>0.05); level of Arg mRNA in TBI+Agomir-20b group was significantly increased at days 3 and 7 postinjury (all P<0.01); level of CD206 mRNA in TBI+Agomir-20b group did not change significantly at day 3 postinjury (P>0.05), but was significantly increased at day 7 postinjury (P<0.01).
ConclusionsmiR-20b can obviously inhibit neuronal apoptosis to improve motor function after TBI in mice, for which the underlying mechanism is related to Agomir-20b inhibiting the transformation of microglia to pro-inflammatory M1 type after TBI.
Key words:
Brain injuries; Neurons; Apoptosis
Contributor Information
Zhao Chengcheng
Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen 518060, China
Department of Neurosurgery, First Affiliated Hospital of Shenzhen University, Shenzhen Second People′s Hospital, Shenzhen 518025, China
Liu Yufei
Department of Neurosurgery, First Affiliated Hospital of Shenzhen University, Shenzhen Second People′s Hospital, Shenzhen 518025, China
Li Yun
Department of Neurosurgery, First Affiliated Hospital of Shenzhen University, Shenzhen Second People′s Hospital, Shenzhen 518025, China
He Yi
Department of Neurosurgery, First Affiliated Hospital of Shenzhen University, Shenzhen Second People′s Hospital, Shenzhen 518025, China
Zhang Xiejun
Department of Neurosurgery, First Affiliated Hospital of Shenzhen University, Shenzhen Second People′s Hospital, Shenzhen 518025, China
Li Weiping
Department of Neurosurgery, First Affiliated Hospital of Shenzhen University, Shenzhen Second People′s Hospital, Shenzhen 518025, China